This information was published on 2018-11-27T08:46:36 for IP Right Registration Published.
| Field | Value |
| (210) | 1922208 (IR 1398334) |
| (220) |
16 Jan 2018
|
| (511) (510) |
Class 5
Pharmaceutical preparations, namely, drugs for the treatment of cancer, inflammation and other diseases related to cell proliferation in humans and animals |
| (540) | NUCLEXPO |
| (550) | Word |
| (730) |
Karyopharm Therapeutics Inc.
|
Find out more about publications on the About page.